Pharmaceutical company, Eli Lilly and Co will release the data from their drug study of Alimta at the end of this month. Alimta is the company's most prominent mesothelioma drug and is also used to treat non small cell lung cancer. Most commonly, Alimta is used in combination with cisplatin for patients who cannot receive surgery.
The data comes from 50 studies and will be released at the American Society of Clinical Oncology meetings from May 29 to June 2 in Orlando, Florida. The results of these studies will be helpful in determining which treatments will work best for which patients. This will make things easier for physicians to prescribe treatments.
If you or someone you know has been diagnosed with mesothelioma, contact the Florida mesothelioma attorneys of Williams Kherkher at 800-781-3955.